Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study

Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study

Abstract Background Mother-to-child transmission (MTCT) is one of the main routes of transmission of HBV, and previous studies focused on the efficacy and safety of nucleoside analogues (NAs) in preventing MTCT. There are limited data on virologic changes of chronic hepatitis B (CHB) patients after...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Qiao Tang, Chunrui Wang, Hu Li, Zhiwei Chen, Li Zhang, Jing Zhang, Xiaoqing Liu, Yunling Xue, Yue Qiu, Mingli Peng, Yi Zeng, Peng Hu
Ձևաչափ:	Հոդված
Լեզու:	English
Հրապարակվել է:	BMC 2025-02-01
Շարք:	Virology Journal
Խորագրեր:	Mother-to-child transmission ALT abnormal Liver fibrosis Virologic response Treatment discontinuation
Առցանց հասանելիություն:	https://doi.org/10.1186/s12985-025-02632-x

Նմանատիպ նյութեր

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
‌: Luisa Roade, և այլն
Հրապարակվել է: (2023-10-01)

Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infection
‌: Ying Yan, և այլն
Հրապարակվել է: (2022-11-01)

Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients
‌: Jing Zhao, և այլն
Հրապարակվել է: (2023-03-01)

Deteksi HBsAg dan HBeAg dalam Saliva Pengidap Virus Hepatitis B
‌: Riemawati A. Lesmana
Հրապարակվել է: (2015-10-01)

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.
‌: Tung-Hung Su, և այլն
Հրապարակվել է: (2013-01-01)

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
‌: Chih-Chien Yao, և այլն
Հրապարակվել է: (2017-05-01)

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia
‌: Crozier Sarah, և այլն
Հրապարակվել է: (2008-04-01)

Quantitative HBsAg: Not helpful to evaluate fibrosis in HBeAg-negative chronic hepatitis B patients
‌: Dimitri Loureiro, և այլն
Հրապարակվել է: (2019-01-01)

Correlation between HBsAg quantitation and HBV DNA in HBeAg-Negative HBV/D patients
‌: Anouar Teriaky, և այլն
Հրապարակվել է: (2013-01-01)

Triple motif proteins 19 and 38 correlated with treatment responses and HBsAg clearance in HBeAg-negative chronic hepatitis B patients during peg-IFN-α therapy
‌: Haiying Luo, և այլն
Հրապարակվել է: (2023-07-01)

Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area
‌: Chen-Hsuan Wu, և այլն
Հրապարակվել է: (2017-04-01)

Coexistence of HBsAg/Anti-HBs and HBeAg/Anti-HBe in Sudanese Patients with Chronic Hepatitis B Virus Infection: A Cross-Sectional Study
‌: Taqwa Hashim, և այլն
Հրապարակվել է: (2023-12-01)

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation
‌: Yifei Guo, և այլն
Հրապարակվել է: (2023-02-01)

Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues.
‌: Teresa Broquetas, և այլն
Հրապարակվել է: (2017-01-01)

Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients
‌: Fatima A Ahmed, և այլն
Հրապարակվել է: (2019-01-01)

Quantitative HBsAg and Qualitative HBeAg Predicts Intrauterine Placental Infection and Umbilical Blood Cord in Pregnant Women
‌: Erry Gumilar Dachlan, և այլն
Հրապարակվել է: (2020-10-01)

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
‌: Cheng-Yuan Peng, և այլն
Հրապարակվել է: (2015-04-01)

CTLA-4 haplotype predicts HBsAg and HBcrAg levels and HBeAg seroconversion age in children with chronic HBV infection
‌: Jia-Feng Wu, և այլն
Հրապարակվել է: (2024-05-01)

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
‌: Shengxia Yin, և այլն
Հրապարակվել է: (2023-12-01)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
‌: Michel Bazinet, և այլն
Հրապարակվել է: (2022-08-01)

Caucasian Ethnicity, but Not Treatment Cessation Is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion
‌: Stijn Van Hees, և այլն
Հրապարակվել է: (2019-07-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
‌: Romina Salpini, և այլն
Հրապարակվել է: (2020-01-01)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
‌: Zhan Zeng, և այլն
Հրապարակվել է: (2023-01-01)

Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients treated with nucleotide analogs plus polyethylene glycol interferon
‌: Yan Peng, և այլն
Հրապարակվել է: (2025-01-01)

Mitogen-activated protein kinase eight polymorphisms are associated with immune responsiveness to HBV vaccinations in infants of HBsAg(+)/HBeAg(−) mothers
‌: Meng Zhuo Cao, և այլն
Հրապարակվել է: (2018-06-01)

Alteration of the Immune Microenvironment in HBsAg and HBeAg Dual-Positive Pregnant Women Presenting a High HBV Viral Load
‌: Gao F, և այլն
Հրապարակվել է: (2021-10-01)

Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.
‌: Elisabetta Loggi, և այլն
Հրապարակվել է: (2013-01-01)

Increased Coffee Intake Reduces Circulating HBV DNA and HBsAg Levels in HBeAg-Negative Infection: A Cohort Study
‌: Jack Bee Chook, և այլն
Հրապարակվել է: (2019-09-01)

Possible immunochemical pattern of anti-HCV, HBeAg, HBsAg HBeAb, and HIV-1 p24 in newly infected Mycobacterium pulmonary tuberculosis patients
‌: Mathew Folaranmi Olaniyan, և այլն
Հրապարակվել է: (2019-01-01)

Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
‌: Won-Mook Choi, և այլն
Հրապարակվել է: (2022-05-01)

Correlation of fulminant hepatitis B, HBeAg start-codon depletions and escape mutations in the 2nd loop of the HBsAg a-determinant
‌: T. Michler, և այլն
Հրապարակվել է: (2014-04-01)

Prevalence of HBe Ag and LFT Survey in HBsAg Positive Blood Donors in Kerman
‌: M.J Zahedi, և այլն
Հրապարակվել է: (2003-07-01)

HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy
‌: K. V. Zhdanov, և այլն
Հրապարակվել է: (2014-09-01)

Study of hepatic histomorphology in HBeAg+ and HBeAg− patients with CHB: Experience from Bangladesh
‌: Ayub Al Mamun, և այլն
Հրապարակվել է: (2013-01-01)

Significant liver histological change is common in HBeAg-positive chronic hepatitis B with normal ALT
‌: Menghui Duan, և այլն
Հրապարակվել է: (2024-07-01)

Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers
‌: Yong Poovorawan, և այլն
Հրապարակվել է: (2012-07-01)

Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA
‌: Jian Wang, և այլն
Հրապարակվել է: (2024-12-01)

Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.
‌: Tai-Long Chien, և այլն
Հրապարակվել է: (2016-01-01)

Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
Հրապարակվել է: (2006-01-01)

PgRNA closely correlates to cytokine profile in HBeAg-positive pregnant women undergoing prophylactic antiviral intervention
‌: Qiao Tang, և այլն
Հրապարակվել է: (2024-12-01)